Obama puts focus on FDA after peanut poisonings

Trinity Health puts sharper focus on geriatric care.

Repurposing of FDA-approved drugs against cancer – focus on metastasis

in the field of anti-cancer drug development. Drug repurposing may allow progressing through the drug development process more quickly as well as reducing project costs compared to traditional de novo drug discovery. One of the main reasons why a non-cancer drug may prove effective against cancer is that not all of its biological targets may have been identified when the drug was originally dev...

Worldwide drug withdrawal puts FDA under scrutiny Merck faces 300 lawsuits Karen

Vioxx is a cyclooxygenase (COX)-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by the USA’s Food and Drug Administration (FDA) in May 1999 for the relief of the signs and symptoms of osteoarthritis, the management of acute pain in adults, and the treatment of menstrual symptoms. Vioxx was later also approved for the relief of signs and symptoms of rheumatoid arthrit...

New FDA guidance on off-label promotion falls short for everyone: obama administration is likely to revisit it.

cept for this important fact: the exemption required companies to submit promotional material to the FDA before distributing it and to apply to the FDA for a supplemental New Drug Application (NDA) for the unapproved use. These two requirements have been eliminated in the new guidance—an omission that has greatly disturbed P&T committees and public inter est groups; these groups see the strippe...

Analysis of Fatal Poisonings Due to Toxic Alcohols and Drugs - Focus On Metabolites

....................................................................................................................... 9